Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.

Byrd, J C; Brown, J R; Obrien, S; Barrientos, J C; Kay, N E; Reddy, N M; Coutre, S; Tam, C S; Mulligan, S P; Jaeger, U; Devereux, D; Barr, P M; Furman, R R; Kipps, T J; Cymbalista, F; Pocock, C; Thorton, P; Caligaris Cappio, F; Robak, T; Delgado, J; Schuster, S J; Montillo, M; Schun, A; de Vos, S; Gill, D; Bloor, A; Dearden, C; Moreno, C; Jones, J J; Chu, A D; Fardis, M; Mcgreivy, J; Clow, F; James, D F; Hillmen, P; Santoro, A